Caris Life Sciences · 3 hours ago
Area Vice President – Molecular Science Liaison (Central)
Caris Life Sciences is dedicated to transforming cancer care through precision medicine and innovative solutions. The Area Vice President of Molecular Science Liaison will lead a team responsible for communicating the value of Caris Molecular Intelligence to external clients, managing team activities, and ensuring effective education and support for the medical community.
Artificial Intelligence (AI)BiopharmaBiotechnologyHealth CareLife Science
Responsibilities
As AVP, this individual would be responsible for management activities such as, but not limited to:
Day to day team management of the MSL team
Providing recommendations on national staffing plans
Creation and coordination of the training and enablement plan to ensure MSLs have the most up-to-date information and education regarding the company’s technology
Tracking of MSLs activities and customer interactions
As AVP, this individual will perform management duties to ensure that each MSL can successfully perform the following responsibilities:
Act as a conduit of information/feedback between the medical community and Caris Life Sciences regarding current products and the needs of the medical community to enhance patient care, new research developments, clinical trial activities and therapeutic approaches
Conduct medical and scientific education and support for the field organization in an effort to increase Caris Life Sciences presence and market awareness
Present clinical data and educational materials to physician sites and/or conferences within an assigned region or nationally, as required by Sales, Caris Precision Oncology Alliance (POA) Team, and Marketing
Attend POA/Commercial pitch meetings and other important relationship development onsite meetings
Promote CMI to physician sites across the United States, as required by Sales, POA, and Marketing initiatives
Support and present at molecular tumor board meetings
Read and understand the scientific and technical literature in order to maintain knowledge of the therapeutic oncology field for customer engagement
Assists with other related duties and special projects as required by sales, POA, and marketing
Assist in field training contracted speakers as part of the Caris Speaker’s Bureau
Function as a field trainer of assigned region to provide an extension of our Director of Training
Regional speaking engagements (Roundtables, Grand Rounds, Tumor Boards, etc.) with physicians to broaden CMI understanding clinically
Attend select regional tradeshows, national tradeshows and participate in sales meetings to present relevant data necessary to promote CMI and educate clients in the marketplace
Commercial input/review of marketing material to reflect current molecular landscape
Qualification
Required
Doctoral degree (e.g., Ph.D., M.D./D.O., PharmD) in a health-related biological science related to pharmacology, oncology, or molecular and cellular biology
3+ years of management experience in Medical Affairs or managing MSLs
Proficient in Microsoft Office Suite, specifically Word, Excel, Outlook, and general working knowledge of Internet for business use
Preferred
Prior commercial experience in the pharmaceutical or diagnostic industry or other relevant health-related science field preferred
Prior field experience working with customers and sales organizations preferred
Benefits
Highly competitive and inclusive medical, dental and vision coverage options
Health Savings Account for medical expenses and dependent care expenses
Flexible Spending Account to pay for certain out-of-pocket expenses
Paid time off, including: vacation, sick time and holidays
401k match and Financial Planning tools
LTD and STD insurance coverages, as well as voluntary benefit options
Employee Assistance Program
Pet Insurance
Legal Assistance
Tuition Assistance
Company
Caris Life Sciences
Caris Life Sciences develops molecular profiling and AI-driven technologies to support precision medicine in oncology.
Funding
Current Stage
Public CompanyTotal Funding
$1.86BKey Investors
BraidwellOrbiMedSixth Street
2025-06-18IPO
2025-04-07Private Equity· $168M
2023-01-19Debt Financing· $400M
Recent News
2025-12-22
2025-12-21
2025-12-19
Company data provided by crunchbase